InfYnity Biomarkers is pleased to announce that our manuscript “The unmet medical need for Trypanosoma cruzi-infected patients: Monitoring the Disease Status” has been published in Biochimica et Biophysica Acta, BBA Molecular Basis of Disease special issue focused on Chagas disease.
In this Mini Review Maan Zrein (CSO of InfYnity Biomarkers) and Eric Chatelain (DNDi) discuss the question:
How to assess treatment efficacy in a timely manner?
Specifically they provide interesting insight into recently identified biomarkers and discuss the power of serological pattern recognition.
For more details please follow the link below
or download the article by clicking here.